drugset / Trial / NCT03922620

Liposomal Bupivacaine vs Peripheral Nerve Block

NCT03922620 ↗

Phase 4 Terminated 1 enrolled Geisinger Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.

Timeline

Start
2020-01-23
Primary completion
2021-06-30
Completion
2021-06-30

Outcome

Outcome not reported

Stopped: “Additional published information on the topic since starting the study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 20 ml Other